Recurrent prostate cancer despite undetectable prostate specific antigen.

Prostate-specific antigen pox virus vaccination for recurrent prostate cancer.

African Americans' Perceptions of Prostate-Specific Antigen Prostate Cancer Screening.

Prostate-specific antigen-based prostate cancer screening: Past and future.

When prostate cancer remains undetectable: The dilemma.

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer.

Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia.

MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer.

Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.

Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report.

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.

Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.

Association between obesity, prostate-specific antigen level and prostate-specific antigen density in men with a negative prostate biopsy.

Association of diet with prostate specific antigen and prostate volume.

Prostate-specific antigen and diagnosing early malignancies of the prostate.

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy.

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.

Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?

A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer.

Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.

Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer.

Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer.

Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.

Suggest Documents

Prostate-specific antigen pox virus vaccination for recurrent prostate cancer.

African Americans' Perceptions of Prostate-Specific Antigen Prostate Cancer Screening.

Prostate-specific antigen-based prostate cancer screening: Past and future.

When prostate cancer remains undetectable: The dilemma.

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer.

Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia.

MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer.

Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.

Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report.

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.

Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.

Association between obesity, prostate-specific antigen level and prostate-specific antigen density in men with a negative prostate biopsy.

Association of diet with prostate specific antigen and prostate volume.

Prostate-specific antigen and diagnosing early malignancies of the prostate.

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy.

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.

Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?

A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer.

Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.

Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer.

Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer.

Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.

Recurrent prostate cancer despite undetectable prostate specific antigen.

Recommend Documents

Follow Us